New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
07:08 EDTRXIIRXi Pharmaceuticals granted US Notice of Allowance for technology platform
RXi Pharmaceuticals received the Notice of Allowance from the USPTO on its novel, self-delivering RNAi platform. The patent broadly covers both the composition and methods of use of RXi's self-delivering platform technology. The patent, once issued, will be scheduled to expire in 2029.
News For RXII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2015
07:51 EDTRXIIRXi Pharmaceuticals receives Orphan Drug Designation for Samcyprone from FDA
Subscribe for More Information
April 16, 2015
08:03 EDTRXIIRXi Pharmaceuticals granted orphan status for melanoma treatment
The FDA granted RXi Pharmaceuticals orphan status for its treatment of malignant melanoma stage IIB to IV Samcyprone.
April 14, 2015
09:13 EDTRXIIOn The Fly: Pre-market Movers.
UP AFTER EARNINGS: JPMorgan Chase (JPM), up 1%... Johnson & Johnson (JNJ), up marginally... Triangle Petroleum (TPLM), up 4.2%... Fastenal (FAST), up 5%. ALSO HIGHER: Brainstorm Cell Therapeutics (BCLI), up 13.5% after announcing that it will present NurOwn Phase 2a clinical data at the Academy of Neurology annual meeting... Builders FirstSource (BLDR), up 7.2% after being upgraded to Buy from Hold at Stifel... Solazyme (SZYM), up 7.5% after announcing a strategic agreement with Flotek (FTK)... Cleveland BioLabs (CBLI), up 6.8% after receiving funding recommendation from the Department of Defense... Nordic American Tanker (NAT), up 3.2% after raising quarterly dividend to 38c from 22c... Ocwen (OCN), up 3.8% after reporting preliminary fiscal 2014 results. DOWN AFTER EARNINGS: Wells Fargo (WFC), down just under 1%. ALSO LOWER: Norfolk Southern (NSC), down 5.8% after being downgraded to Hold from Buy at TD Securities... RXi Pharmaceuticals (RXII), down 14.3% after filing to sell $20M of common stock and warrants... Arrowhead Research (ARWR), down 4.5% after being downgraded to Hold from Buy at Jefferies.
April 13, 2015
17:25 EDTRXIIRXi Pharmaceuticals files to sell $20M of common stock, warrants
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use